
Wende Hutton
General Partner · Canaan Partners
General PartnerSan Francisco Bay Area, CA
Wende Hutton is a general partner at Canaan, where she has invested since 2004 in companies bringing novel drugs, technologies and devices to market, partnering with founders to deliver more than a dozen innovations to patients. She began her venture career as a general partner at Mayfield and previously held senior marketing roles at GenPharm and Nellcor. She holds an A.B. in human biology from Stanford and an MBA from Harvard Business School.
Board seats
LAST CHECKED NOV 2026
Credited hits
9
· PUBLIC SOURCES
Midas years
LAST CHECKED NOV 2026
Founder rating
LAST CHECKED NOV 2026
Maintained from public sources. Not claimed. If you're Wende Hutton, you can claim this profile.
Claim this profileHow claiming worksClaiming verifies identity and affiliation. It does not permit editing reviews, scores, or cited facts.
Track record
- Alsius Corporationacquired
Listed under Previous investments on her Canaan bio page as acquired by Zoll.
Source: canaan.com
- Apieronacquired
Listed under Previous investments on her Canaan bio page as acquired by Aerocrine.
Source: canaan.com
- BiPar Sciencesacquired
Listed under Previous investments on her Canaan bio page as acquired by Sanofi-Aventis.
Source: canaan.com
- Calibra Medicalacquired
Listed under Previous investments on her Canaan bio page as acquired by LifeScan / Johnson & Johnson.
Source: canaan.com
- Chimerixipo
Listed under Previous investments on her Canaan bio page as an IPO.
Source: canaan.com
- Dermiraipo
Listed under Previous investments on her Canaan bio page as an IPO.
Source: canaan.com
- Labrys Biologicsacquired
Listed under Previous investments on her Canaan bio page as acquired by Teva Pharmaceutical.
Source: canaan.com
- Northstar Neuroscienceipo
Listed under Previous investments on her Canaan bio page as an IPO.
Source: canaan.com
- Transcend Medicalacquired
Listed under Previous investments on her Canaan bio page as acquired by Alcon / Novartis.
Source: canaan.com
Board seats
Current board seats · —
Board seats
Success signals
Forbes Midas List
No public record
Not listed.
Reputation
No reputation score — basis not established for this investor.
No reputation sources on file yet.
Suggest a sourceContact
Published sources only
Published contact details collected from public sources. Not a referral, and not an introduction.
Published contact
- Website
- www.canaan.com
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
Claimed profiles can replace or remove contact details.
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with Wende Hutton. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewFirm-level reviews are not attributed to Wende Hutton.
Methodology
This profile carries no tier: tier belongs to the firm and is shown only via the linked firm name — never inherited onto a person.
Credited deals, board seats, Midas years and reputation links are carried per investor in the catalog, each item with the public source it was credited from, linked from the sections above. Fields with no sourced record render their honest null states, and every published field traces to the catalog record listed below. Review dimension scores appear only at three or more reviews.
Corrections with a source: Suggest a correction.
Source record 1
- [1]
DATABASE · GlassVC catalog — Catalog record for Wende Hutton — provenance: GlassVC catalog
↩ cites: Title · Firm · Type · Bio · Location · Focus · Credited deals
EVERY FIGURE ON THIS PAGE IS TRACEABLE TO THE CATALOG RECORD ABOVE · LAST CHECKED NOV 2026
